Influence of gender and age on the survival of patients with nasopharyngeal carcinoma

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Xiao, Guangli ^a   Cao, Yabing ^a   Qiu, Xibin ^a   Wang, Weihua ^a   Wang, Yufeng ^a  

^a Macao Special Administrative Region of the People's Republic of China   (Macao)

Author keywords

Age and survival; Gender; NPC

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; ADOLESCENT; AGE; COMPUTER ASSISTED RADIOTHERAPY; FOLLOW UP; METASTASIS; MIDDLE AGED; MORTALITY; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PROGNOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84876968103     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-226     Document Type: Article

References (21)

1. The Health Bureau of the Macao Special Administrative Region Government Annual report of Macao cancer registry 2009, The electronic version of this article is the complete one and can be found online at: http://www.ssm.gov.mo/, The Health Bureau of the Macao Special Administrative Region Government.
2. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005, 61(4):1107-1116. 10.1016/j.ijrobp.2004.07.702, 15752890.
3. Ma J, Mai HQ, Hong MH, Cui NJ, Lu TX, Lu LX, Mo HY, Min HQ. Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?. Int J Radiat Oncol Biol Phys 2001, 50(5):1181-1189. 10.1016/S0360-3016(01)01537-1, 11483327.
4. Ng WT, Chan SH, Lee AW, Lau KY, Yau TK, Hung WM, Lee MC, Choi CW. Parapharyngeal extension of nasopharyngeal carcinoma: still a significant factor in era of modern radiotherapy?. Int J Radiat Oncol Biol Phys 2008, 72(4):1082-1089. 10.1016/j.ijrobp.2008.02.006, 18410997.
5. Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 2005, 62(3):672-679. 10.1016/j.ijrobp.2004.11.002, 15936544.
6. Yun-sheng G, Chao-su H, Hong-mei Y, Guo-pei Z, Lin K, Xia-yun H, Ting-ting X, Xiao-shen W, Jing Y, Su-qin W. Treatment results of nasopharyngeal carcinoma : a retrospective analysis of 1837 cases in a single institute. Chinese J radiat oncol 2008, 17(5):5.
7. Chen CY, Han F, Zhao C, Lu LX, Sun Y, Liu XF, Lu TX. Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone. Br J Radiol 2009, 82(978):452-458. 10.1259/bjr/72813246, 19451314.
8. Chong Z, Wei-wei X, Fei H, Li-xia L, Shao-xiong W, Jian-zhou C, Cheng-guang L, Shao-min H, Xiao-wu D, Tai-xiang L. Long-term outcome and prognostic factors of patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy 2010, 19(3). ONCOLOGY: CHINESE JOURNAL OF RADIATION.
9. Jian-ji P, Yu Z, Shao-jun L, Ling Y, Lu-ying X, Chuan-ben C, Cai-zhu P. Long-term results of nasopharyngeal carcinoma treated with radiotherapy: 1706 cases report. Chinese j radiat oncol 2008, 17(4):5.
10. Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai WM, Xiao JP, Xu GZ. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int J Radiat Oncol Biol Phys 2006, 65(1):161-168. 10.1016/j.ijrobp.2005.12.003, 16542792.
11. Lai SZ, Li WF, Chen L, Luo W, Chen YY, Liu LZ, Sun Y, Lin AH, Liu MZ, Ma J. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?. Int J Radiat Oncol Biol Phys 2011, 80(3):661-668. 10.1016/j.ijrobp.2010.03.024, 20643517.
12. Liu X, Luo W, Liu M, Ye L, Sun Y, Xia Y. Treatment results and prognostic analysis of 1093 primary nasopharyngeal carcinoma: the experience of a single institution of Guangzhou in the beginning of the 21st century. Chin-Ger J Clin Oncol 2008, 7(4):187-195.
13. Nasr HB, Chahed K, Bouaouina N, Chouchane L. Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression. Clin chim acta int j clin chem 2008, 395(1-2):124-129.
14. Jung KW, Park S, Shin A, Oh CM, Kong HJ, Jun JK, Won JK. Do female cancer patients display better survival rates compared with males? analysis of the Korean national registry data, 2005-2009. PLoS One 2012, 7(12):e52457. http://www.plosone.org, 10.1371/journal.pone.0052457, 3530449, 23300677.
15. Joosse A, Collette S, Suciu S, Nijsten T, Lejeune F, Kleeberg UR, Coebergh JWW, Eggermont AMM, Vries E. Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European organisation for research and treatment of cancer phase III trials. J Clin Oncol 2012, 30(18):2240-2247. 10.1200/JCO.2011.38.0584, 22547594.
16. Wolf M, Holle R, Hans K, Drings P, Havemann K. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival. Br J Cancer 1991, 63:986-992. 10.1038/bjc.1991.215, 1972562, 1648949.
17. Gupta A, Driscoll MS. Do hormones influence melanoma? Facts and controversies. Clin Dermatol 2010, 28:287-292. 10.1016/j.clindermatol.2010.04.003, 20541681.
18. Lens M, Bataille V. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Cancer Causes Contr 2008, 19:437-442.
19. Garay JP, Karakas B, Abukhdeir AM, Cosgrove DP, Gustin JP, Higgins MJ, Konishi H, Konishi Y, Lauring J, Mohseni M. The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation. Breast Cancer Res 2012, 14:R27. 10.1186/bcr3112, 3496145, 22321971.
20. Gucalp A, Traina TA. Triple-negative breast cancer: role of the androgen receptor. Cancer J 2010, 16:62-65. 10.1097/PPO.0b013e3181ce4ae1, 20164692.
21. Maasberg M, Jaques G, Rotsch M, Enderle-Schmidt U, Weehle R, Havemann K. Androgen receptors, androgen dependent proliferation, and 5-reductase activity of small cell lung cancer cell lines. Int J Cancer 1989, 43:685-691. 10.1002/ijc.2910430424, 2539332.